Abstract
Although major advances have been made in solid organ and hematopoietic stem cell transplantation in the last 50 years, big challenges remain. This review outlines the current immunological limitations for hematopoietic stem cell and solid organ transplantation and discusses new immune-modulating therapies in preclinical development and in clinical trials that may allow these obstacles to be overcome.
Original language | English (US) |
---|---|
Article number | 280rv2 |
Journal | Science Translational Medicine |
Volume | 7 |
Issue number | 280 |
DOIs | |
State | Published - Mar 25 2015 |
Bibliographical note
Publisher Copyright:© 2015, AAAS. All rights reserved.